PSA 4.0 ng/mL: What Happens Next?
PSA is not a cancer diagnosis. A result around 4 ng/mL is interpreted with age, prior PSA values, prostate size, medications, infection history and other findings.
High PSA: BPH vs Prostate Cancer
Both benign prostatic hyperplasia and prostate cancer can be associated with an elevated PSA. Prostatitis and other non-cancer causes can raise it too.
Free PSA vs Total PSA: What Changes the Decision?
Total PSA measures the overall prostate-specific antigen in blood. Percent-free PSA looks at the fraction circulating unbound and can be used as an additional risk-refining test in selected men.
PSA Density Before Biopsy: Why Prostate Volume Matters
PSA density relates PSA to prostate volume. The logic is simple: a larger benign prostate can produce more PSA, so the same PSA value can carry different meaning at different gland sizes.
Repeat PSA Before Biopsy: When a Second Test May Matter
PSA can vary over time. When an initial result is borderline, some clinicians repeat it before moving to more invasive testing.
Phase 1 expanded decision guides
PSA 3.0 ng/mL: What Happens Next?
A PSA around 3 ng/mL is not a diagnosis. The next step depends on age, prior PSA values, prostate size, medications, family history and whether the result is new or rising.
PSA 4.5 ng/mL: What Happens Next?
A PSA of 4.5 ng/mL falls in a range where benign enlargement, inflammation and prostate cancer can overlap. Clinicians usually interpret it in context rather than using the number alone.
PSA 5 ng/mL: Repeat Test, MRI or Biopsy?
A PSA around 5 ng/mL commonly triggers a more deliberate risk assessment, especially if it is new, rising or unexplained. It still does not diagnose cancer.
PSA 10 ng/mL: What Happens Next?
A PSA around 10 ng/mL generally deserves prompt clinical evaluation because the probability of clinically important prostate disease is higher than with borderline values, although benign causes remain possible.
High PSA With a Negative MRI: Biopsy or Monitoring?
A negative prostate MRI lowers the chance of some clinically significant cancers but does not reduce the risk to zero. Persistent PSA elevation still needs a risk-based plan.
Rising PSA After a Negative Biopsy: What Comes Next?
A prior negative biopsy lowers risk but does not permanently close the diagnostic pathway. Continued PSA rise may justify reassessment, particularly when no prior prostate MRI was performed.
High PSA With a Large Prostate: How Prostate Size Changes the Picture
A larger benign prostate can produce more PSA, which is why prostate volume and PSA density can materially change interpretation of the same blood result.
PSA Density 0.15: How to Interpret the Threshold
PSA density divides PSA by prostate volume. Values around 0.15 are often discussed as one risk marker, especially when MRI findings are equivocal or negative, but no single cutoff should decide biopsy alone.
PSA Velocity: When a Fast-Rising PSA Changes the Conversation
PSA velocity describes how quickly PSA changes over time. A rapid rise can prompt closer evaluation, but PSA kinetics should be interpreted with the absolute value and clinical context.
Low Percent-Free PSA: What Happens Next?
Percent-free PSA is sometimes used to refine cancer risk when total PSA is in a borderline range. Lower percentages can increase concern, but the test does not diagnose cancer.
PHI Test vs Prostate MRI: Which Comes First After an Elevated PSA?
The Prostate Health Index (PHI) is a blood-based risk-refining test, while prostate MRI provides anatomical imaging and lesion assessment. They answer different questions and can be complementary.
4Kscore vs Prostate MRI After High PSA
4Kscore is a blood-based risk estimate for aggressive prostate cancer; mpMRI looks for suspicious lesions and can guide biopsy targeting. Neither is a biopsy.
PSA After Prostatitis: When Should It Be Rechecked?
Prostate inflammation can raise PSA. When prostatitis is suspected or treated, clinicians may wait and repeat PSA after the acute issue has settled rather than interpreting the inflammatory result as a stable baseline.
High PSA After a UTI: What to Do Before MRI or Biopsy
Urinary infection and inflammation can complicate PSA interpretation. A clinician may defer repeat PSA until the infection has resolved, depending on the overall risk picture.
PSA After Ejaculation: Can It Affect a Repeat Test?
Ejaculation can cause a small temporary PSA change in some men. When a borderline result is being repeated, clinicians or laboratories may give preparation instructions to reduce avoidable variability.
Cycling Before a PSA Test: Does It Matter?
Some clinicians advise avoiding vigorous cycling shortly before PSA testing because perineal pressure may add variability, although evidence is mixed. Consistent test conditions can still be sensible for borderline values.
PSA While Taking Finasteride: Why the Number Needs Adjustment
Finasteride can lower PSA substantially over time, so clinicians interpret PSA differently in men taking it. The medication history must be known before comparing the result with untreated reference values.
PSA While Taking Dutasteride: What a Rise From Baseline Can Mean
Dutasteride suppresses PSA over time. After a new baseline is established, an unexpected rise can matter even when the absolute number looks modest.
Repeat PSA or MRI First? A Decision Guide After an Elevated Result
When PSA is newly elevated, repeating the blood test may be reasonable in some situations before moving to MRI; in others, the baseline risk is high enough that imaging should not be delayed.